School of Medicine


Showing 1-10 of 13 Results

  • Neeladrisingha Das

    Neeladrisingha Das

    Postdoctoral Scholar, Radiation Physics

    BioNeel is a postdoc fellow in the Pratx lab at Stanford University. He is currently working on the role of radiotherapy in cancer cell death and the various mechanism involved in radio-induced cell death. Neel comes from a very small town in Odisha, India (Athgarh) and had schooling in his hometown. He had a keen interest in animal biology and started his B.S in Zoology at Gopabandhu Science College, Athgarh. Later he did his M.S in Zoology from Sambalpur University, Odisha, India. He carried out his doctoral studies at the Indian Institute of Technology Roorkee in the lab of Prof. Partha Roy. His main study was on the anti-cancer activity of various natural-based products and their mechanism of action. Neel is a trained cell and molecular biologist. His research interest includes- Cancer cell death mechanisms and developing therapeutics for cancer stem cells and metastasis.

  • Pardis Miri

    Pardis Miri

    Postdoctoral Scholar, Genetics

    BioPardis Miri, PhD, is a postdoctoral fellow at Stanford University where she is focused on building technology to facilitate mental well being. With a PhD in computer science and years of training in area of affective science (under the supervision of Professor James J. Gross), Pardis has assembled a unique team (see http://wehab.stanford.edu) to not only run clinical studies to evaluate their efficacy in changing emotion, mood, and stress but also build product-ready technology.

    Pardis is the principal investigator of a large multi-disciplinary project (FAR) to design, build, and evaluate a wearable system tailored to the needs of children with emotion dysregulation, especially children diagnosed with autism spectrum disorder. FAR aims to empower them to manage their problem behaviors in a more adaptive way. The FAR project involves collaborations between the departments of Computer Science, Psychology, Mechanical Engineering, and the School of Medicine at Stanford University.

    Pardis is being advised by Professors Micheal Snyder, Professor Keith Marzullo at the University of Maryland iSchool, whose research is on distributed systems, and by Professor James Gross, whose research underlies much of what we now know about emotion regulation. She is also working with Professor Antonio Hardan of the Stanford School of Medicine, whose research is on children with Autism Spectrum Disorder.

  • Dhriti Nagar

    Dhriti Nagar

    Postdoctoral Scholar, Neonatal and Developmental Medicine

    BioPremature birth is a leading cause of developmental and neuropsychiatric disorders in children. One of the factors causing these defects is lowered levels of available oxygen (hypoxia) in the newborn due to immature lungs. My research focuses on understanding the cellular and molecular mechanisms underlying hypoxia-induced developmental disorders of the nervous system due to preterm birth.

  • Michitaka Nakano

    Michitaka Nakano

    Basic Life Research Scientist, Medicine - Med/Hematology

    BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.

  • Kerem Nernekli

    Kerem Nernekli

    Temp - Non-Exempt, Rad/Pediatric Radiology

    BioDr. Nernekli has a wide-ranging research background encompassing molecular imaging, surgical neuroanatomy, clinical outcome studies, and machine learning, focusing on medical image reconstruction and multimodal deep learning algorithms for classification and segmentation tasks. Currently, he is focused on investigating novel radiotracer and activatable Gd-based contrast agents to detect senescence in large animal models with PET/MRI. Furthermore, Dr. Nernekli is exploring the potential of ferumoxytol-MRI and two-photon microscopy to correlate theranostic nanoparticles in their natural environment in order to gain a deeper understanding of their interactions with tumor-associated microenvironments.

  • Kouta Niizuma

    Kouta Niizuma

    Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute

    BioI am a Research Scientist in Prof. Hiromitsu Nakauchi's laboratory at Stanford University. I obtained my PhD in Immunology from the University of Tsukuba, Japan. During my doctoral studies in Prof. Akira Shibuya's laboratory, I focused on the characterization of cell surface receptors expressed on immune cells. I successfully cloned a novel human immunoglobulin-like receptor, CD300H, and established a specific monoclonal antibody. My research demonstrated that CD300H is expressed on a subset of human monocytes and dendritic cells and plays a crucial role in enhancing inflammation by promoting the production of inflammatory cytokines and chemokines.

    During my PhD, I also studied as a visiting scholar in Prof. Lewis L. Lanier's laboratory at UCSF, where I investigated the role of the activating receptor NKG2D on NK cells in viral immunity.

    Since May 2018, I have been a member of the Nakauchi lab. My current research focuses on the development of new immunotherapies using myeloid cells derived from iPS cells, the generation of monoclonal antibodies, and hematopoietic stem cell biology.